(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -32.79%546.71K | 126.18%180.17K | 164.83%595.62K | -34.67%1.45M | 267.29%2.24M | 1.97%813.4K | -410.04%-688.05K | -197.26%-918.68K | 132.52%2.22M | -5.41%610.49K |
Net income from continuing operations | 1,974.51%122.67K | 758.89%490.41K | 540.21%226K | -207.43%-1.7M | -1,115.31%-1.66M | -98.17%5.91K | -112.95%-74.43K | -95.69%35.3K | 91.97%1.58M | -118.98%-136.94K |
Operating gains losses | --0 | --0 | ---40K | ---25K | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | -4.45%319.67K | 44.21%424.06K | -3.44%342.76K | 17.78%1.65M | 25.92%662.85K | 13.92%334.56K | 8.21%294.05K | 15.97%354.95K | 25.47%1.4M | 104.95%526.39K |
Asset impairment expenditure | ---- | ---- | ---- | --1.01M | ---- | ---- | ---- | ---- | --0 | ---- |
Deferred tax | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -200.00%-186.29K | ---- |
Other non cashItems | --0 | --0 | -76.02%531 | 6.50%84.96K | 15.63%79.74K | -59.61%1.27K | -51.71%1.74K | -45.56%2.21K | -51.19%79.78K | 27.11%68.96K |
Change In working capital | -77.87%104.38K | 19.26%-734.3K | 105.06%66.33K | 166.09%432.07K | 544.54%2.18M | 164.79%471.66K | 7.65%-909.42K | -606.76%-1.31M | -159.92%-653.78K | -33.42%338.38K |
-Change in receivables | 60.16%177.89K | -10.09%47.13K | -414.66%-405.54K | 356.22%321.34K | 210.55%28.96K | 63.76%111.07K | 384.42%52.42K | 186.72%128.88K | 74.06%-125.42K | 26.39%-26.2K |
-Change in inventory | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 93.40%9.76K | ---- |
-Change in prepaid assets | -178.97%-73.51K | -102.78%-2.26K | -99.63%-86.24K | 68.11%-35.84K | -1,653.99%-167.13K | 174.86%93.09K | 6,650.00%81.41K | ---43.2K | -565.28%-112.39K | 130.51%10.76K |
-Change in payables and accrued expense | -100.00%-1 | 25.31%-779.18K | 139.96%558.11K | 134.43%146.57K | 574.05%2.32M | 14.00%267.5K | -7.82%-1.04M | -3,685.44%-1.4M | -274.60%-425.74K | -39.03%344.06K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -32.79%546.71K | 126.18%180.17K | 164.83%595.62K | -34.67%1.45M | 267.29%2.24M | 1.97%813.4K | -410.04%-688.05K | -197.26%-918.68K | 132.52%2.22M | -5.41%610.49K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 17.90%-1.09M | 11.24%-711.93K | -51.53%-3.83M | 36.66%-5.27M | 88.93%-613.75K | -29.50%-1.33M | 25.83%-802.11K | -277.63%-2.53M | -230.57%-8.32M | -540.41%-5.54M |
Net PPE purchase and sale | --42.5K | --0 | ---317K | 78.23%-164.84K | 38.83%-164.84K | --0 | --0 | --0 | 69.92%-757.06K | 68.87%-269.49K |
Net other investing changes | --5.17M | 11.24%-711.93K | -38.98%-3.51M | 32.50%-5.11M | ---- | ---- | ---802.11K | ---2.53M | ---7.56M | ---7.25M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 17.90%-1.09M | 11.24%-711.93K | -51.53%-3.83M | 36.66%-5.27M | 88.93%-613.75K | -29.50%-1.33M | 25.83%-802.11K | -277.63%-2.53M | -230.57%-8.32M | -540.41%-5.54M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 512.80%395.45K | 99.91%-88 | 91.32%3.97M | -102.43%-249.36K | -2,125.42%-2.13M | -0.00%-95.8K | -100.91%-95.8K | 1,685.43%2.07M | 538.47%10.26M | -169.28%-95.8K |
Net common stock issuance | ---- | ---- | --4.16M | --0 | ---- | ---- | ---- | --0 | 606.24%10.71M | --0 |
Proceeds from stock option exercised by employees | --0 | --0 | --0 | --146.25K | --0 | --0 | --0 | --146.25K | --0 | --0 |
Net other financing activities | 512.80%395.45K | 4,438.75%4.16M | -109.77%-188.35K | 12.16%-395.61K | -2,125.42%-2.13M | -0.00%-95.8K | 25.13%-95.8K | 1,573.63%1.93M | -45.73%-450.37K | 77.98%-95.8K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 512.80%395.45K | 99.91%-88 | 91.32%3.97M | -102.43%-249.36K | -2,125.42%-2.13M | -0.00%-95.8K | -100.91%-95.8K | 1,685.43%2.07M | 538.47%10.26M | -169.28%-95.8K |
Net cash flow | ||||||||||
Beginning cash position | -67.86%431.12K | -67.10%962.97K | -94.70%227.97K | 2,852.18%4.3M | -92.11%731.33K | -86.10%1.34M | 908.71%2.93M | 2,852.18%4.3M | 42.04%145.61K | 2,207.85%9.27M |
Current changes in cash | 75.79%-147.65K | 66.47%-531.85K | 153.60%735K | -198.02%-4.07M | 89.87%-503.35K | -59.13%-609.89K | -116.94%-1.59M | -1,048.47%-1.37M | 9,536.88%4.15M | -1,841.39%-4.97M |
End cash Position | -61.24%283.47K | -67.86%431.12K | -67.10%962.97K | -94.70%227.97K | -94.70%227.97K | -92.11%731.33K | -86.10%1.34M | 908.71%2.93M | 2,852.18%4.3M | 2,852.18%4.3M |
Free cash from | -48.63%-5.71M | 126.18%180.17K | 130.33%278.62K | -16.88%1.21M | 187.31%6.66M | -2,177.86%-3.84M | 28.73%-688.05K | -433.57%-918.68K | 193.44%1.46M | 1,152.21%2.32M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data